Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome
- PMID: 7587434
- DOI: 10.1378/chest.108.5.1303
Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome
Abstract
Background: Inflammatory cytokines (ICs) are important modulators of injury and repair. ICs have been found to be elevated in the BAL of patients with both early and late ARDS. We tested the hypothesis that recurrent injury to the alveolocapillary barrier and amplification of intra-alveolar fibroproliferation observed in nonresolving ARDS is related to a persistent inflammatory response. For this purpose, we obtained serial measurements of BAL IC and correlated these levels with lung injury score (LIS), BAL indexes of endothelial permeability (albumin, total protein [TP]), and outcome.
Methods: We prospectively studied 27 consecutive patients with severe medical ARDS. Using enzyme-linked immunosorbent assay methods, levels of tumor necrosis factor-alpha (TNF-alpha) and interleukins (IL) 1 beta, 2, 4, 6, and 8 were measured at frequent intervals in both plasma and BAL. In 22 patients, bilateral BAL was obtained on day 1 of ARDS and at weekly intervals when possible. Right and left BALs were analyzed separately for IC levels, total cell count and differential, albumin, TP, and quantitative bacterial cultures.
Results: On day 1 of ARDS, the 10 nonsurvivors had significantly higher (p = 0.0002) BAL TNF-alpha, IL-1 beta, IL-6, and IL-8 levels, which remained persistently elevated over time, indicating a continuous injury process. In contrast, the 12 survivors had a lesser elevation and a rapid reduction over time. Initial BAL IL-2 and IL-4 levels were significantly higher in patients with sepsis (p = 0.006); both increased over time in survivors and nonsurvivors. BAL levels of TNF-alpha, IL-1 beta, IL-6, and IL-8 correlated with BAL albumin and TP concentrations but not with LIS or ratio of arterial oxygen tension to inspired oxygen concentration. BAL: plasma ratios were elevated for all measured cytokines, suggesting a pulmonary origin. On day 1 of ARDS, nonsurvivors had significantly higher (p = 0.04) BAL: plasma ratios for TNF-alpha, IL-1 beta, IL-6, and IL-8. Over time, BAL:plasma ratios for TNF-alpha, IL-1 beta and IL-6 remained elevated in nonsurvivors and decreased in survivors.
Conclusions: Our findings indicate that an unfavorable outcome in ARDS is associated with an initial, exaggerated, pulmonary inflammatory response that persists unabated over time. Plasma IC levels parallel changes in BAL IC levels. The BAL:plasma ratio results suggest, but do not prove, a pulmonary origin for IC production. BAL TNF-alpha, IL-1 beta, and IL-8 levels correlated with BAL indices of endothelial permeability. In survivors, reduction in BAL IC levels over time was associated with a decline in BAL albumin and TP levels, suggesting effective repair of the endothelial surface. These findings support a causal relationship between degree and duration of lung inflammation and progression of fibroproliferation in ARDS.
Similar articles
-
Plasma and BAL cytokine response to corticosteroid rescue treatment in late ARDS.Chest. 1995 Nov;108(5):1315-25. doi: 10.1378/chest.108.5.1315. Chest. 1995. PMID: 7587435
-
Infections and the inflammatory response in acute respiratory distress syndrome.Chest. 1997 May;111(5):1306-21. doi: 10.1378/chest.111.5.1306. Chest. 1997. PMID: 9149588
-
Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time.Chest. 1995 Apr;107(4):1062-73. doi: 10.1378/chest.107.4.1062. Chest. 1995. PMID: 7705118
-
The role of the host defence response in the progression and outcome of ARDS: pathophysiological correlations and response to glucocorticoid treatment.Eur Respir J. 1996 Dec;9(12):2650-70. doi: 10.1183/09031936.96.09122650. Eur Respir J. 1996. PMID: 8980983 Review.
-
Oxidant-antioxidant balance in acute lung injury.Chest. 2002 Dec;122(6 Suppl):314S-320S. doi: 10.1378/chest.122.6_suppl.314s. Chest. 2002. PMID: 12475808 Review.
Cited by
-
Renal artery thrombosis in SARS-CoV-2 infection: a case report.BMC Nephrol. 2022 May 6;23(1):175. doi: 10.1186/s12882-022-02808-5. BMC Nephrol. 2022. PMID: 35524226 Free PMC article.
-
Does activation of the FcgammaRIIa play a role in the pathogenesis of the acute lung injury/acute respiratory distress syndrome?Clin Sci (Lond). 2010 Jan 26;118(8):519-26. doi: 10.1042/CS20090422. Clin Sci (Lond). 2010. PMID: 20088831 Free PMC article.
-
Resolving lung injury: a new role for Tregs in controlling the innate immune response.J Clin Invest. 2009 Oct;119(10):2891-4. doi: 10.1172/JCI40880. Epub 2009 Sep 21. J Clin Invest. 2009. PMID: 19770510 Free PMC article.
-
Timeline Kinetics of Systemic and Airway Immune Mediator Storm for Comprehensive Analysis of Disease Outcome in Critically Ill COVID-19 Patients.Front Immunol. 2022 Jun 3;13:903903. doi: 10.3389/fimmu.2022.903903. eCollection 2022. Front Immunol. 2022. PMID: 35720401 Free PMC article.
-
Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients.Eur Respir J. 2022 Dec 15;60(6):2200780. doi: 10.1183/13993003.00780-2022. Print 2022 Dec. Eur Respir J. 2022. PMID: 35896211 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources